{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:20:07Z","timestamp":1788884407105,"version":"build-2803163510"},"reference-count":39,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran","award":["1402-2-221-66993"],"award-info":[{"award-number":["1402-2-221-66993"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,24]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Polypharmacy, defined as the concurrent use of multiple medications, is a growing concern among the elderly, especially in low-income and middle-income countries such as Iran. This study aims to explore the prevalence and patterns of polypharmacy among the elderly in Iran, using health insurance claims data to identify common drug classes and coprescribed medications, with a focus on informing policy decisions and improving medication management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective population-based observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Nationwide data from the Iran Health Insurance Organization (IHIO) across 24 provinces.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1\u2009876\u2009527 individuals aged 65 years and older, insured by the IHIO from 2014 to 2017. Individuals with incomplete demographic information or lacking medication records in the database were excluded from the analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Prevalence and patterns of polypharmacy, demographic factors associated with polypharmacy, and common drug classes used. Medications were classified using the Anatomical Therapeutic Chemical system. Polypharmacy was defined as the use of five or more medications, with cumulative polypharmacy considering total drug use over time, and consecutive polypharmacy focusing on the frequency of monthly drug use. Logistic regression and association rule mining were applied to explore demographic factors and medication patterns associated with polypharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the study population, 74.9% experienced cumulative polypharmacy over 6\u2009months and 64.6% over 1\u2009month, with 7.6% experiencing consecutive polypharmacy. Females and those aged 75\u201379 were more prone to polypharmacy. Systemic glucocorticoids were the most commonly used medications (50.02%), followed by HMG-CoA reductase inhibitors (42.73%) and platelet aggregation inhibitors (41.92%). Polypharmacy was most strongly associated with medications related to the alimentary tract and metabolism, cardiovascular system, nervous system and blood and blood-forming organs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Polypharmacy is highly prevalent among the elderly in Iran, with significant variations by gender, age, insurance fund and region. The findings highlight the need for targeted interventions to manage polypharmacy and improve medication safety in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097863","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:20:35Z","timestamp":1755768035000},"page":"e097863","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6463-4784","authenticated-orcid":false,"given":"Seyed Mohammad-Navid","family":"Ataei","sequence":"first","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Golestani","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Khosravi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-9721","authenticated-orcid":false,"given":"Ozra","family":"Tabatabaei-Malazy","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Malekpour","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbube","family":"Ebrahimpur","sequence":"additional","affiliation":[{"name":"Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Sadat","family":"Mirzadeh","sequence":"additional","affiliation":[{"name":"Clinical Gerontology & Geriatric Department, Medical School, Tehran University of Medical Sciences, Ziaeian Hospital, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shahali","sequence":"additional","affiliation":[{"name":"National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Amini","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Effatpanah","sequence":"additional","affiliation":[{"name":"National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)"},{"name":"School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"2025123106471487000_15.8.e097863.1","unstructured":"World Health Organization . Medication safety in polypharmacy: technical report. Contract No.: WHO\/UHC\/SDS\/2019.11. Geneva World Health Organization; 2019."},{"key":"2025123106471487000_15.8.e097863.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr"},{"key":"2025123106471487000_15.8.e097863.3","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-021-00479-3"},{"key":"2025123106471487000_15.8.e097863.4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jocn.15595","article-title":"Polypharmacy and pattern of medication use in community-dwelling older adults: A systematic review","volume":"30","author":"Hsu","year":"2021","journal-title":"J Clin Nurs"},{"key":"2025123106471487000_15.8.e097863.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.10.022"},{"key":"2025123106471487000_15.8.e097863.6","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13153"},{"key":"2025123106471487000_15.8.e097863.7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"Wirtz","year":"2017","journal-title":"Lancet"},{"key":"2025123106471487000_15.8.e097863.8","unstructured":"World Health Organization . Promoting rational use of medicines: core components. Geneva World Health Organization; 2002. Available: https:\/\/iris.who.int\/handle\/10665\/67438"},{"key":"2025123106471487000_15.8.e097863.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03628.x"},{"key":"2025123106471487000_15.8.e097863.10","article-title":"Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data","volume":"35","author":"Kamyari","year":"2021","journal-title":"Med J Islam Repub Iran"},{"key":"2025123106471487000_15.8.e097863.11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/2279-042X.137058","article-title":"Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran: A cross-sectional study","volume":"3","author":"Karimi","year":"2014","journal-title":"J Res Pharm Pract"},{"key":"2025123106471487000_15.8.e097863.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60240-2"},{"key":"2025123106471487000_15.8.e097863.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-020-01372-4","article-title":"Iran health insurance system in transition: equity concerns and steps to achieve universal health coverage","volume":"20","author":"Doshmangir","year":"2021","journal-title":"Int J Equity Health"},{"key":"2025123106471487000_15.8.e097863.14","unstructured":"Iran Data Portal . Census 2016. 2016. Available: https:\/\/irandataportal.syr.edu\/census\/census-2016 [Accessed 12 Aug 2024]."},{"key":"2025123106471487000_15.8.e097863.15","unstructured":"WHO collaborating centre for drug statistics methodology. ATC, structure and principles: Norwegian Institute of Public Health. 2024. Available: https:\/\/atcddd.fhi.no\/atc\/structure_and_principles"},{"key":"2025123106471487000_15.8.e097863.16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.therap.2019.10.001","article-title":"Polypharmacy: A general review of definitions, descriptions and determinants","volume":"75","author":"Guillot","year":"2020","journal-title":"Therapie"},{"key":"2025123106471487000_15.8.e097863.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234386","article-title":"Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study","volume":"15","author":"Al-Dahshan","year":"2020","journal-title":"PLoS One"},{"key":"2025123106471487000_15.8.e097863.18","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1097\/PTS.0000000000000439","article-title":"Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia","volume":"17","author":"Balkhi","year":"2021","journal-title":"J Patient Saf"},{"key":"2025123106471487000_15.8.e097863.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098043","article-title":"Prevalence and predictors of polypharmacy among Korean elderly","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"2025123106471487000_15.8.e097863.20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/ggi.13880","article-title":"Drug prescription patterns and factors associated with polypharmacy in >1 million older adults in Tokyo","volume":"20","author":"Ishizaki","year":"2020","journal-title":"Geriatrics Gerontology Int"},{"key":"2025123106471487000_15.8.e097863.21","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20126","article-title":"Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data","volume":"149","author":"Schneider","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"2025123106471487000_15.8.e097863.22","doi-asserted-by":"publisher","DOI":"10.1159\/000503298"},{"key":"2025123106471487000_15.8.e097863.23","doi-asserted-by":"crossref","DOI":"10.3402\/gha.v7.25484","article-title":"Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs","volume":"7","author":"Chilet-Rosell","year":"2014","journal-title":"Glob Health Action"},{"key":"2025123106471487000_15.8.e097863.24","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90003-6"},{"key":"2025123106471487000_15.8.e097863.25","doi-asserted-by":"crossref","DOI":"10.4103\/jehp.jehp_93_19","article-title":"Healthcare-seeking behavior and its relating factors in South of Iran","volume":"8","author":"Khajeh","year":"2019","journal-title":"J Educ Health Promot"},{"key":"2025123106471487000_15.8.e097863.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-024-04848-y","article-title":"Determinants of multimorbidity in older adults in Iran: a cross-sectional study using latent class analysis on the Bushehr Elderly Health (BEH) program","volume":"24","author":"Marzban","year":"2024","journal-title":"BMC Geriatr"},{"key":"2025123106471487000_15.8.e097863.27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jamda.2015.08.009","article-title":"Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency","volume":"17","author":"Onder","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"2025123106471487000_15.8.e097863.28","doi-asserted-by":"publisher","DOI":"10.2165\/11631750-000000000-00000"},{"key":"2025123106471487000_15.8.e097863.29","first-page":"384","article-title":"The outcomes of health care process in Iran\u2019s rural society","volume":"18","author":"Eskandari","year":"2013","journal-title":"Iran J Nurs Midwifery Res"},{"key":"2025123106471487000_15.8.e097863.30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.32598\/sija.2022.16.4.767.2","article-title":"Prevalence of Chronic Diseases Among the Older Adults in Iran: Does Socioeconomic Status Matter?","volume":"16","author":"Mohaqeqi Kamal","year":"2022","journal-title":"Salmand"},{"key":"2025123106471487000_15.8.e097863.31","first-page":"115","article-title":"Prescription pattern among Iranian community dwelling older adults","volume":"16","author":"Saboor","year":"2019","journal-title":"Med Glas (Zenica)"},{"key":"2025123106471487000_15.8.e097863.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-022-02872-7","article-title":"Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran","volume":"22","author":"Mohsenzadeh","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2025123106471487000_15.8.e097863.33","first-page":"250","article-title":"Uses, adverse effects of abuse of corticosteroids. Part I","volume":"22","author":"Imam","year":"1994","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2025123106471487000_15.8.e097863.34","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.2284"},{"key":"2025123106471487000_15.8.e097863.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32585-5"},{"key":"2025123106471487000_15.8.e097863.36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025123106471487000_15.8.e097863.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1059","article-title":"Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity","volume":"350","author":"Marengoni","year":"2015","journal-title":"BMJ"},{"key":"2025123106471487000_15.8.e097863.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2009.02040.x"},{"key":"2025123106471487000_15.8.e097863.39","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s41999-021-00583-4","article-title":"Deprescribing or represcribing: not just a semantic dilemma","volume":"13","author":"Wehling","year":"2022","journal-title":"Eur Geriatr Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:49:06Z","timestamp":1767192546000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2024-097863"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097863","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}